Please login or sign up to post and edit reviews.
BioNTech's Covid Vaccine Expected to Generate $11 Billion in Revenue
Publisher |
Barron's
Media Type |
audio
Categories Via RSS |
Business
Business News
Investing
News
Publication Date |
Apr 05, 2021
Episode Duration |
00:04:04
BioNTech feels like a household name, but it's still an early-stage biotech. The price of rhodium is on the rise. And the International Monetary Fund and World Bank's spring meetings go virtual. Host: Nicholas Jasinski. Producer: Katie Ferguson.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review